Document is current
Any future updates will be listed below
-
Authors
Pappas, Leontios
Adalsteinsson, Viktor A. https://orcid.org/0000-0003-4555-2485
Parikh, Aparna R. https://orcid.org/0000-0002-5245-7841
- License Information
-
More Information
Article History
First Online: 20 December 2022
Competing interests
: A.R.P. reports equity in C2i Genomics XGenomes and Parithera, and in the past 36 months, has served as an advisor/consultant for Eli Lilly, Pfizer, Inivata, Biofidelity, Natera, Checkmate Pharmaceuticals, FMI, Guardant, Abbvie, Bayer, Delcath, Taiho, CVS, Value Analytics Lab, Seagen, Inivata Saga and Scarce Illumnia. She receives fees from Up to Date. She has been on the Data and Safety Monitoring Committee for a Roche study and on the Steering Committee for Exilixis. She has received research funding to the Institution from PureTech, PMV Pharmaceuticals, Plexxicon, Takeda, BMS, Mirati, Novartis, Erasca, Genentech and Daiichi Sankyo. V.A.A. reports patient applications filed on liquid biopsy sequencing and analysis methods.
